• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-483和miR-214对食管鳞状细胞癌预后及多药耐药性的预测价值

Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.

作者信息

Zhou Yi, Hong Liu

机构信息

Department of Colorectal Surgery, Tianjin Union Medicine Center, Tianjin, China.

出版信息

Genet Test Mol Biomarkers. 2013 Jun;17(6):470-4. doi: 10.1089/gtmb.2012.0518. Epub 2013 May 13.

DOI:10.1089/gtmb.2012.0518
PMID:23721345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3668496/
Abstract

BACKGROUND AND AIMS

Here, we have investigated the role of miR-483 and miR-214 in the prognosis and multidrug resistance (MDR) of esophageal squamous cell carcinoma.

METHODS

The expression of miR-483 and miR-214 was detected in 104 cases of esophageal cancer tissues and matched adjacent benign esophageal tissues by quantitative real-time PCR. The relation of microRNA expression with survival was statistically analyzed. The roles of miR-483 and miR-214 in MDR of esophageal squamous cell cancer cells were further evaluated.

RESULTS

The expression of miR-483 and miR-214 was found significantly upregulated in esophageal squamous cell cancer tissues. The expression levels of miR-483 and miR-214 showed an inverse correlation with overall survival. High expression of miR-483 and miR-214 might predict less chemotherapy effect. Downregulation of miR-483 and miR-214 could confer sensitivity of both P-glycoprotein-related and P-glycoprotein-nonrelated drugs to esophageal cancer cells, and it might induce increased accumulation of adriamycin (ADR) and decreased amount of ADR released.

CONCLUSIONS

miR-483 and miR-214 might play important roles in the pathogenesis of esophageal cancer and should be considered as potential targets for intervention in this malignancy.

摘要

背景与目的

在此,我们研究了miR - 483和miR - 214在食管鳞状细胞癌预后及多药耐药(MDR)中的作用。

方法

采用定量实时聚合酶链反应(PCR)检测104例食管癌组织及配对的癌旁良性食管组织中miR - 483和miR - 214的表达。对微小RNA表达与生存的关系进行统计学分析。进一步评估miR - 483和miR - 214在食管鳞状细胞癌细胞多药耐药中的作用。

结果

发现miR - 483和miR - 214在食管鳞状细胞癌组织中显著上调。miR - 483和miR - 214的表达水平与总生存期呈负相关。miR - 483和miR - 214的高表达可能预示化疗效果较差。下调miR - 483和miR - 214可使食管癌细胞对P - 糖蛋白相关和P - 糖蛋白非相关药物均产生敏感性,且可能导致阿霉素(ADR)蓄积增加及释放量减少。

结论

miR - 483和miR - 214可能在食管癌发病机制中起重要作用,应被视为该恶性肿瘤干预的潜在靶点。

相似文献

1
Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.miR-483和miR-214对食管鳞状细胞癌预后及多药耐药性的预测价值
Genet Test Mol Biomarkers. 2013 Jun;17(6):470-4. doi: 10.1089/gtmb.2012.0518. Epub 2013 May 13.
2
Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.下调 miR-27a 可能逆转食管鳞癌细胞的多药耐药性。
Dig Dis Sci. 2010 Sep;55(9):2545-51. doi: 10.1007/s10620-009-1051-6. Epub 2009 Dec 4.
3
The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.miR-296 在食管鳞癌中的预后和化疗价值。
Ann Surg. 2010 Jun;251(6):1056-63. doi: 10.1097/SLA.0b013e3181dd4ea9.
4
Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.通过 microRNAs 探讨食管鳞癌化疗耐药和生物学特性的复杂表观遗传学调控
Int J Mol Sci. 2018 Feb 7;19(2):499. doi: 10.3390/ijms19020499.
5
MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.微小RNA-367是食管鳞状细胞癌患者的一种潜在诊断生物标志物。
Biochem Biophys Res Commun. 2016 Apr 29;473(2):363-9. doi: 10.1016/j.bbrc.2016.01.042. Epub 2016 Jan 9.
6
Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus.miR-21、miR-29c、miR-148和miR-203在食管腺癌和鳞状细胞癌中的诊断及预后潜力
Diagn Pathol. 2015 Apr 28;10:42. doi: 10.1186/s13000-015-0280-6.
7
Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.微小RNA-100在食管鳞状细胞癌中的预后价值
J Surg Res. 2014 Dec;192(2):515-20. doi: 10.1016/j.jss.2014.07.005. Epub 2014 Jul 6.
8
Caveolin-1 affects tumor drug resistance in esophageal squamous cell carcinoma by regulating expressions of P-gp and MRP1.小窝蛋白-1通过调节P-糖蛋白和多药耐药相关蛋白1的表达影响食管鳞状细胞癌的肿瘤耐药性。
Tumour Biol. 2016 Jul;37(7):9189-96. doi: 10.1007/s13277-015-4778-z. Epub 2016 Jan 14.
9
High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.高TUG1表达与食管鳞状细胞癌的化疗耐药及不良预后相关。
Cancer Chemother Pharmacol. 2016 Aug;78(2):333-9. doi: 10.1007/s00280-016-3066-y. Epub 2016 Jun 21.
10
Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.miR-3651作为食管鳞状细胞癌新型预后生物标志物的临床潜力
Biochem Biophys Res Commun. 2015 Sep 11;465(1):30-4. doi: 10.1016/j.bbrc.2015.07.109. Epub 2015 Jul 23.

引用本文的文献

1
MiRNAs: main players of cancer drug resistance target ABC transporters.微小RNA:癌症耐药性的主要作用靶点是ABC转运蛋白。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 14. doi: 10.1007/s00210-024-03719-y.
2
Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view.miRNAs 在多柔比星耐药中的调控作用:一种机制观点。
Funct Integr Genomics. 2024 Sep 2;24(5):150. doi: 10.1007/s10142-024-01431-x.
3
Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by Analysis of Differential Gene Expression.揭示血清 miR-483-5p 的潜力:通过差异基因表达分析,作为 OLp 和 OSCC 患者的有前途的诊断和预后生物标志物。
Curr Pharm Des. 2024;30(4):310-322. doi: 10.2174/0113816128276149240108163407.
4
Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer.高表达的miR-27a、miR-206和miR-214与三阴性乳腺癌患者预后不良及化疗耐药性增加相关。
Am J Cancer Res. 2023 Jun 15;13(6):2471-2487. eCollection 2023.
5
miRNAs as Biomarkers and Possible Therapeutic Strategies in Synovial Sarcoma.微小RNA作为滑膜肉瘤的生物标志物及可能的治疗策略
Front Pharmacol. 2022 Aug 8;13:881007. doi: 10.3389/fphar.2022.881007. eCollection 2022.
6
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.头颈部癌症中有前景的生物标志物:最具临床意义的 miRNAs。
Int J Mol Sci. 2022 Jul 26;23(15):8257. doi: 10.3390/ijms23158257.
7
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.微小RNA、长链非编码RNA和环状RNA在食管癌耐药中的新意义
Front Cell Dev Biol. 2021 Nov 22;9:764313. doi: 10.3389/fcell.2021.764313. eCollection 2021.
8
Blood-based circulating microRNAs as potential biomarkers for predicting the prognosis of head and neck cancer-a systematic review.基于血液的循环 microRNAs 作为预测头颈部癌症预后的潜在生物标志物:系统评价。
Clin Oral Investig. 2020 Nov;24(11):3833-3841. doi: 10.1007/s00784-020-03608-7. Epub 2020 Oct 3.
9
Circulating miR-19a-3p and miR-483-5p as Novel Diagnostic Biomarkers for the Early Diagnosis of Gastric Cancer.循环 miR-19a-3p 和 miR-483-5p 作为胃癌早期诊断的新型诊断生物标志物。
Med Sci Monit. 2020 Jun 3;26:e923444. doi: 10.12659/MSM.923444.
10
Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.循环 microRNAs 作为人类头颈部癌症的预后分子生物标志物:系统评价和荟萃分析。
Dis Markers. 2019 Nov 18;2019:8632018. doi: 10.1155/2019/8632018. eCollection 2019.

本文引用的文献

1
MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.微小 RNA-98 和微小 RNA-214 在后转录水平上调节胚胎外胚层发育蛋白同源物 2,并抑制人食管鳞状细胞癌的迁移和侵袭。
Mol Cancer. 2012 Aug 6;11:51. doi: 10.1186/1476-4598-11-51.
2
MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.微小RNA-214通过PTEN/AKT途径调节表皮生长因子受体(EGFR)突变细胞系对吉非替尼的获得性耐药。
Asian Pac J Cancer Prev. 2012;13(1):255-60. doi: 10.7314/apjcp.2012.13.1.255.
3
Emerging role of microRNAs in drug-resistant breast cancer.微小RNA在耐药性乳腺癌中的新作用
Gene Expr. 2011;15(3):141-51. doi: 10.3727/105221611x13176664479287.
4
MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release.MicroRNA-214 通过靶向 Quaking 并减少血管生成生长因子的释放来抑制血管生成。
Cardiovasc Res. 2012 Mar 15;93(4):655-65. doi: 10.1093/cvr/cvs003. Epub 2012 Jan 6.
5
MicroRNAs in mutagenesis, genomic instability, and DNA repair.微小 RNA 在诱变、基因组不稳定性和 DNA 修复中的作用。
Semin Oncol. 2011 Dec;38(6):743-51. doi: 10.1053/j.seminoncol.2011.08.003.
6
MicroRNA involvement in esophageal carcinogenesis.微小 RNA 参与食管癌变。
Curr Opin Pharmacol. 2011 Dec;11(6):612-6. doi: 10.1016/j.coph.2011.09.006. Epub 2011 Oct 10.
7
MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.肾上腺皮质肿瘤的 microRNA 图谱分析显示 miR-483 可作为恶性肿瘤的标志物。
Cancer. 2011 Apr 15;117(8):1630-9. doi: 10.1002/cncr.25724. Epub 2010 Nov 8.
8
Angiogenesis-related molecular targets in esophageal cancer.食管癌中与血管生成相关的分子靶点。
Expert Opin Investig Drugs. 2011 May;20(5):637-44. doi: 10.1517/13543784.2011.571203. Epub 2011 Mar 28.
9
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.微小 RNA 483-3p 抑制胰腺癌中 DPC4/Smad4 的表达。
FEBS Lett. 2011 Jan 3;585(1):207-13. doi: 10.1016/j.febslet.2010.11.039. Epub 2010 Nov 27.
10
Dysregulation of miR-15a and miR-214 in human pancreatic cancer.miR-15a 和 miR-214 在人胰腺癌细胞中的失调。
J Hematol Oncol. 2010 Nov 24;3:46. doi: 10.1186/1756-8722-3-46.